Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Details for Patent: 5,607,690

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 5,607,690 protect, and when does it expire?

Patent 5,607,690 protects FLECTOR and is included in one NDA.

This patent has ten patent family members in nine countries.

Summary for Patent: 5,607,690
Title: External anti-inflammatory and analgesic plaster preparation
Abstract:An external anti-inflammatory and analgesic plaster preparation includes as an active ingredient a salt of diclofenac, 2[(2,6-dichlorophenyl)amino]benzene-acetic acid, with a cyclic organic having the general formula (I): ##STR1## wherein X is a group of the formula --(CH.sub.2)m-- in which m is an integer of 0 or 1 and n is an integer of 2 and a pH value of the preparation is adjusted to a range of 7.3 to 9.0.
Inventor(s): Akazawa; Mitsuji (Kagawa, JP)
Assignee: Teikoku Seiyaku Co., Ltd. (Kagawa, JP) Altergon S.A. (Lugano, CH)
Application Number:08/579,469
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,607,690
Patent Claim Types:
see list of patent claims
Compound; Composition; Process;

Drugs Protected by US Patent 5,607,690

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Inst Biochem FLECTOR diclofenac epolamine PATCH;TOPICAL 021234-001 Jan 31, 2007 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,607,690

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan5-119246Apr 23, 1993

International Family Members for US Patent 5,607,690

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 194828   Start Trial
Canada 2121065   Start Trial
Germany 69425292   Start Trial
European Patent Office 0621263   Start Trial
Spain 2149225   Start Trial
Greece 3034616   Start Trial
Japan 3526887   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.